“…Early MUEs in the 1960s and 1970s commonly focused on evaluating distributive-or clinicalbased models of pharmacy services. 1,2 In the 1980s, the Joint Commission started to focus on a structured, pharmacy-based, Pharmacy and Therapeutics (P&T) committee-approved process for reviewing antibiotic use. As medication costs and regimen complexities increased, this evolved into a requirement for hospitals to also review other classes of medications to receive accreditation.…”